Non-FcR-binding, humanized anti-CD3 antibody Hu291 induces apoptosis of human T cells more effectively than OKT3 and is immunosuppressive in vivo

By Carpenter P.A.   Tso J.Y.   Press O.W.   Yu X.-Z.   Anasetti C.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1545-1546

Elsevier

Access to resources Recommend Favorite

The OKT3 antibody response study: a multicentre study of human anti-mouse antibody (HAMA) production following OKT3 use in solid organ tranplantation

By Kimball J.   Norman D.   Shield C.   Schroeder T.   Lisi P.   Garovoy M.   O'Connell J.   Stuart F.   McDiarmid S.   Wall W.  

Transplant Immunology, Vol. 3, Iss. 3, 1995-09 ,pp. : 212-221

Elsevier

Access to resources Recommend Favorite

One center's experience with OKT3 in renal transplantation: patient and graft survival, complications, and cost analysis

By Guz G.   Emiroglu R.   Demirhan B.   Koseoglu F.   Karakayali H.   Bilgin N.  

Transplantation Proceedings, Vol. 32, Iss. 3, 2000-05 ,pp. : 572-573

Elsevier

Access to resources Recommend Favorite

Long-Term Outcome With the Use of OKT3 Induction Therapy in Heart Transplant Patients: A Single-Center Experience

By Adamson R.   Obispo E.   Dychter S.   Dembitsky W.   Moreno-Cabral R.   Jaski B.   Gordon J.   Hoagland P.   Moore K.   King J.   Andrews J.   Rich M.   Daily P.O.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1107-1109

Elsevier

Access to resources Recommend Favorite

Tacrolimus for Steroid- and OKT3-Resistant Rejection in Kidney Recipients

By Kliem V.   Petersen R.   Ehlerding G.   Schaumann D.   Eisenberger U.   Koch K.M.   Pichlmayr R.   Brunkhorst R.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1251-1253

Elsevier

Access to resources Recommend Favorite